Literature DB >> 31511990

Texture analysis of pretreatment [18F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy.

Wen-Jie Wu1, Zhen-Yu Li1, Shuang Dong1, Shu-Ming Liu1, Lei Zheng1, Ming-Wei Huang2, Jian-Guo Zhang1.   

Abstract

BACKGROUND: The aim of this study was to evaluate the prognostic value of positron emission tomography (PET) parameters and the PET texture features of fluorine 18-fluorodeoxyglucose ([18F]FDG) uptake on pretreatment PET/computed tomography (CT) in patients with locally advanced salivary gland carcinoma treated with interstitial brachytherapy.
METHODS: Forty-three patients with locally advanced salivary gland carcinoma of the head and neck were treated with 125I interstitial brachytherapy as the sole modality and underwent [18F]FDG PET/CT scanning before treatment. Tumor segmentation and texture analysis were performed using the 3D slicer software. In total, 54 features were extracted and categorized as first-order statistics, morphology and shape, gray-level co-occurrence matrix, and gray-level run length matrix. Up to November 2018, the follow-up time ranged from 6 to 120 months (median 18 months). Cumulative survival was calculated by the Kaplan-Meier method. Factors between groups were compared by the log-rank test. Multivariate Cox regression analysis with a backward conditional method was used to predict progression-free survival (PFS).
RESULTS: The 3- and 5-year locoregional control (LC) rates were 55.4% and 37.0%, respectively. The 3- and 5-year PFS rates were 51.2% and 34.1%, respectively. The 3- and 5-year overall survival (OS) rates were 77.0% and 77.0%, respectively. Univariate analysis revealed that minimum intensity, mean intensity, median intensity, root mean square, and long run emphasis (LRE) were significant predictors of PFS, whereas clinicopathological factors, conventional PET parameters, and PET texture features failed to show significance. Multivariate Cox regression analysis showed that minimum intensity and LRE were significant predictors of PFS.
CONCLUSIONS: The texture analysis of pretreatment [18F]FDG PET/CT provided more information than conventional PET parameters for predicting patient prognosis of locally advanced salivary gland carcinoma treated with interstitial brachytherapy. The minimum intensity was a risk factor for PFS, and LRE was a favorable factor in prognostic prediction according to the primary results.

Entities:  

Keywords:  Brachytherapy; PET/CT; Prognosis; Salivary gland carcinoma; Texture analysis

Year:  2019        PMID: 31511990      PMCID: PMC6738371          DOI: 10.1186/s13550-019-0555-0

Source DB:  PubMed          Journal:  EJNMMI Res            Impact factor:   3.138


  4 in total

1.  Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Kenta Miwa; Kensuke Otani; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Ann Nucl Med       Date:  2021-05-04       Impact factor: 2.668

Review 2.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

3.  Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.

Authors:  Zhongke Wang; Kaixuan Huang; Xiaolin Yang; Kaifeng Shen; Ling Yang; Ruotong Ruan; Xianjun Shi; Miao Wang; Gang Zhu; Meihua Yang; Chunqing Zhang; Shengqing Lv; Hui Yang; Xiaotang Fan; Shiyong Liu
Journal:  Brain Pathol       Date:  2021-02-10       Impact factor: 6.508

4.  Prognostication Based on Texture Analysis of Baseline 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Nonsmall-Cell Lung Carcinoma Patients Who Underwent Platinum-Based Chemotherapy as First-Line Treatment.

Authors:  Akshima Sharma; Anil Kumar Pandey; Anshul Sharma; Geetanjali Arora; Anant Mohan; Ashu Seith Bhalla; Lalit Gupta; Shiba Kalyan Biswal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2021-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.